» Articles » PMID: 24432248

What Factors Impact Upon a Woman's Decision to Undertake Genetic Cancer Testing?

Overview
Journal Front Oncol
Specialty Oncology
Date 2014 Jan 17
PMID 24432248
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The advent of human genome project has lead to genetic tests that identify high-risk states for certain cancers. Many are privately marketed on the Internet. Despite the availability of tests, limited data has evaluated factors that lead to test uptake. The aim of the present study was to explore the attitudes of a cohort of new mothers toward uptake of a genetic cancer test with a 50% predictive value of cancer.

Methods: A cross-sectional survey was undertaken. The project targeted women who had recently given birth at an Australian tertiary referral hospital. Women were asked about a theoretical blood test that detected an increased risk for the development of cancer. Attitudes and knowledge questionnaires were completed.

Results: Of 232 consecutive women approached, 32 declined, giving a response rate of 86.2%. Only 63 (31.5%) women stated they would have the test. Absence of religious belief, higher level of education, better knowledge of terms used in genetics, an absence of concern over emotional, employment, and insurance discrimination, and previous acceptance of Down syndrome screening in pregnancy were each associated with significantly higher rate of test uptake in univariate analysis (all p < 0.03). In multivariate analysis, a lack of concern over discrimination and a history of having accepted Down syndrome screening in the previous pregnancy remained significantly associated with test uptake (all p < 0.0001).

Conclusion: Concern over discrimination and having made a prior decision to have genetic testing were the principal factors associated with decision-making.

Citing Articles

Effects of personal cancer history and genomic risk information on mothers' psychological adaptation to inherited breast/ovarian cancer syndrome.

Chaillet K, Sleiman Jr M, Yockel M, Peshkin B, Chiang J, Isaacs C Psychol Health Med. 2024; 30(2):297-308.

PMID: 39433288 PMC: 11750615. DOI: 10.1080/13548506.2024.2417311.


Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing.

Tiller J, Bakshi A, Dowling G, Keogh L, McInerney-Leo A, Barlow-Stewart K Eur J Hum Genet. 2023; 32(3):286-294.

PMID: 37169978 PMC: 10923945. DOI: 10.1038/s41431-023-01373-1.


Factors Associated with the Uptake of Genetic Testing for Cancer Risks: A Pathway Analysis Using the Health Information National Trends Survey Data.

Dong X, Huang J, Yi Y, Zhang L, Li T, Chen Y Life (Basel). 2022; 12(12).

PMID: 36556389 PMC: 9786267. DOI: 10.3390/life12122024.


Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.

Tiller J, McInerney-Leo A, Belcher A, Boughtwood T, Gleeson P, Delatycki M BMC Med Ethics. 2021; 22(1):63.

PMID: 34020638 PMC: 8138092. DOI: 10.1186/s12910-021-00634-2.


Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.

McInerney-Leo A, Duncan E Front Endocrinol (Lausanne). 2021; 11:628946.

PMID: 33679611 PMC: 7933540. DOI: 10.3389/fendo.2020.628946.


References
1.
Chilaka V, Konje J, Stewart C, Narayan H, Taylor D . Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn. 2001; 21(3):159-64. DOI: 10.1002/1097-0223(200103)21:3<159::aid-pd20>3.0.co;2-v. View

2.
Godard B, Pratte A, Dumont M, Simard-Lebrun A, Simard J . Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genet Test. 2007; 11(1):45-54. DOI: 10.1089/gte.2006.9998. View

3.
Hendriks K, Hendriks M, Birnie E, Grosfeld F, Wilde A, van den Bout J . Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm. 2008; 5(5):719-24. DOI: 10.1016/j.hrthm.2008.01.032. View

4.
Bostick R, Sprafka J, Virnig B, Potter J . Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med. 1994; 23(6):816-26. DOI: 10.1006/pmed.1994.1139. View

5.
Heshka J, Palleschi C, Howley H, Wilson B, Wells P . A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med. 2008; 10(1):19-32. DOI: 10.1097/GIM.0b013e31815f524f. View